Weight loss on GLP-1s comes from both fat and muscle, she explains
3 Takeaways from the Landmark Oral GLP-1 'Switch' Trial for Obesity Care The Weight Maintenance Challenge As clinicians on the front lines of obesity medicine, we are intimately familiar with the central challenge our patients face: sustaining weight loss after a period of initial success
Consequently, ROS damage the different parts of cells, including lipids, proteins and nucleic acid that leads to several chronic and degenerative conditions like aging, dementia, cardiovascular diseases, kidney diseases, neurodegeneration, cancer, respiratory disorder, rheumatoid arthritis as well as several other metabolic ailments [2]
Similar results were seen in the non-inferiority HARMONY 7 trial, which compared liraglutide versus albiglutide [46]
Factors like sun exposure can speed up the return of your original pigmentation